BioSpace News Archive

GNS Healthcare, a leading AI-driven precision medicine, announced results of a recently published collaboration that uncovered transcription factor PHF19 as a novel marker of aggressive multiple myeloma progression in newly diagnosed patients.

Dr. Thao Truong Pascual has assumed the clinical leadership role for DaVita’s growing nephrology practice management arm

Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates, today announced that Dr. Behzad Aghazadeh, Executive Chairman, is scheduled to participate in virtual fireside chats at the following healthcare conferences: Jefferies Virtual Healthcare Conference on Thursday, June 4 at 3:30 p.m. Eastern Time Goldman Sachs 41st Annual Global Healthcar

IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQB:IGXT) (“ IntelGenx ” or the “ Corporation ”) today announced that it intends to issue shares of common stock (“ Common Shares ”) of the Corporation in payment of the outstanding $7,577,000 aggregate principal amount of the Corporation’s 8.00% convertible unsecured subordinated debentures due June 30, 2020 (the “ Debentures ”). Under the terms of the trust indenture governing the Debentures

Intec Pharma Ltd. (NASDAQ: NTEC) (“Intec” or “the Company”) today announces that the Company management will present at the Jefferies Virtual Healthcare Conference. Jefferies Virtual Healthcare Conference Date: June 2 – June 4, 2020 Company Presentation: Thursday, June 4, 2020 at 4:00 pm (ET) Presenter: Jeffrey A. Meckler ,

scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, chief executive officer, will present at the following investor conferences in June: Jefferies Virtual Healthcare Conference Presentation: Thurs